Testing effectiveness (Phase 2)Active Not RecruitingNCT05509023
What this trial is testing
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
Who this might be right for
Atopic Dermatitis
Q32 Bio Inc. 102